(MASI) Masimo - Ratings and Ratios

Masimo Corporation (NASDAQ:MASI) is a global leader in the development, manufacturing, and marketing of advanced patient monitoring technologies, automation, and connectivity solutions. The companys core innovation, Masimo Signal Extraction Technology (SET), addresses the limitations of conventional pulse oximetry by providing accurate monitoring during motion and low perfusion conditions. Building on this foundation, Masimo offers the Rainbow SET platform, which enables noninvasive measurement of multiple parameters, including oxygen saturation, carboxyhemoglobin, methemoglobin, and hemoglobin levels, as well as advanced metrics like pleth variability index and oxygen reserve index. The platform also integrates acoustic respiration monitoring, NomoLine capnography, and regional oximetry for comprehensive patient assessment.

Expanding beyond pulse oximetry, Masimo provides brain function and hemodynamic monitoring solutions, patient position and activity tracking, and neuromodulation technologies. The Masimo Hospital Automation platform includes a suite of solutions such as Patient SafetyNet, Replica, Iris, and Centroid, designed to enhance patient safety and streamline clinical workflows. Additionally, the company offers nasal high-flow respiratory support therapy and telehealth solutions, addressing a broad spectrum of healthcare needs. Masimo distributes its products through a global network of direct sales teams, distributors, and original equipment manufacturer (OEM) partners, serving hospitals, emergency medical services, home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Its home wellness products are also available through e-commerce platforms like masimopersonalhealth.com, Amazon, and Shopify.

Masimo Corporation, founded in 1989 and headquartered in Irvine, California, has established itself as a pioneer in noninvasive monitoring technologies, continually advancing the standard of care in patient monitoring and beyond. For more information, visit https://www.masimo.com.

Ticker Symbol: MASI Exchange: NASDAQ Type: common stock Country Origin: United States GICS Sub Industry: Health Care Equipment

3-Month Forecast: Based on and , Masimo Corporation (MASI) is expected to face headwinds in the near term. The stock is currently trading below its SMA 50 (167.90) and SMA 20 (156.75), with a last price of 157.93, indicating potential resistance at higher levels. The average true range (ATR) of 8.86 suggests moderate volatility, while the SMA 200 (149.77) may act as a support level. On the fundamental side, the high forward P/E of 40.00 and negative RoE (-28.99%) raise concerns about valuation and profitability. However, the companys strong market position in patient monitoring and its diversified product portfolio may offset some risks. Investors should monitor earnings reports and industry trends for clarity on future performance.